STE · STERIS plc (Ireland)
$218.40
+5.47% last session
End-of-day data · updated 2026-07-29
Market cap
$22B
Enterprise value
$24B
Trailing P/E
29.1
Forward P/E
18.9
Dividend yield
1.0%
Beta
0.92
Avg volume
1M
Employees
18K
2D change
5.47%
5D change
—
10D change
5.74%
30D change
8.02%
60D change
8.60%
MTD change
8.50%
YTD change
-8.64%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — STE
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-28
Latest call per bank · past 12 months
UBS
Buy$275
+25.9% vs priceMorgan Stanley
Overweight$295
+35.1% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-28 | UBS | Initiates | Buy | $0.00 → $275 |
| 2026-05-13 | Keybanc | Maintains | Overweight | $291 → $269 |
| 2025-08-08 | Morgan Stanley | Maintains | Overweight | $276 → $295 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 65 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 8.6% above the 50-day MA ($212.09).
- Price vs 200-day MA: Trading 1.5% below the 200-day MA ($233.88).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+0.99) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($199.40) and high ($267.17).
STE Price Chart
Loading chart for STE…
Fundamentals
About STERIS plc (Ireland)
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
More in Medical Devices
SYK
Stryker Corporation
$133B -0.9% YTD
BSX
Boston Scientific Corporation
$68B -51.7% YTD
EW
Edwards Lifesciences Corporatio
$48B -1.8% YTD
GEHC
GE HealthCare Technologies Inc.
$29B -21.7% YTD
DXCM
DexCom, Inc.
$29B 12.8% YTD
PHG
Koninklijke Philips N.V. NY Reg
$25B -2.0% YTD
ZBH
Zimmer Biomet Holdings, Inc.
$19B 7.1% YTD
SNN
Smith & Nephew SNATS, Inc.
$14B 0.7% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.